Recent trends in the impurity profile of pharmaceuticals

Journal of Advanced Pharmaceutical Technology and Research

Volumn 1, Issue 3, 2010, Pages 302-310

  Pilaniya, Kavita ^a   Chandrawanshi, Harish K ^b,e   Pilaniya, Urmila ^b   Manchandani, Pooja ^c   Jain, Pratishtha ^d   Singh, Nitin ^d  

^a Shivdan Singh Institute of Technology and Management   (India)

^b VNS Institute of Pharmacy   (India)

^c SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^d Oriental College of Pharmacy   (India)

^e Department of Pharmaceutics ^*  (India)

Author keywords

Characterization; chromatography; identification; impurities; mass spectrometry; NMR

Indexed keywords

BENZOCAINE; CEFPODOXIME; CHARCOAL; CHLORAMPHENICOL; CHLORDIAZEPOXIDE; CHROMIUM; CIPROFLOXACIN; COPPER; ERGOMETRINE; ETHYL PARABEN; HEAVY METAL; IRIDIUM; IRON; LINCOMYCIN; MANGANESE; MOLYBDENUM; NICKEL; NIFEDIPINE; OFLOXACIN; PENICILLIN G; PHENOBARBITAL; PHENOTHIAZINE; PLATINUM; RIBOFLAVIN; RUBIDIUM; TETRAHYDROFURAN; VANADIUM; ZINC;

CAPILLARY ELECTROPHORESIS; CATALYSIS; CHEMICAL REACTION KINETICS; CRYSTALLIZATION; DECARBOXYLATION; DRUG IMPURITY; DRUG MANUFACTURE; ELECTRON SPIN RESONANCE; ENANTIOMER; GAS LIQUID CHROMATOGRAPHY; GRAVIMETRY; HEAVY METAL REMOVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INFRARED SPECTROSCOPY; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; RESIDUE ANALYSIS; REVIEW; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; SOLVENT EFFECT; SPECTROPHOTOMETER; SUPERCRITICAL FLUID CHROMATOGRAPHY; TREND STUDY;

EID: 79952928580     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/0110-5558.72422     Document Type: Review

References (27)

1. Keitel S. Impurity Profiles in Active Pharmaceutical Ingredients. EU/Swissmedic GMP Workshop Beijing University; Sep. 2006.
2. Josephs JL, Sanders M, Shipkova P. Detection and Characterization of Pharmaceutical Metabolites, Degradants and Impurities by the Application of MS/MS Software Algorithms; Technical Program. Feb 25, 2007.
3. Condorelli G, De Guidi G, Giulfrido S. Molecular mechanisms of photosensitization induced by drugs XII. Photochemistry and photosensitization of rufloxacin: An unusual photodegradation path for the antibacterials containing a fluoroquinolone like chromophore. Photochem Photobiol 1999;70:280-6. (Pubitemid 129555873)
4. Connor KA, Amidon GL, Stella VJ. Chemical Stability of Pharmaceuticals-A Handbook for Pharmacists. 2 nd ed. New York: John Wiley and Sons; 1986. p. 182-4.
5. Hoerle SL, Evans KD, Snider BG. HPLC Determination of Impurities in a 3 rd Generation Cephalosporin. Somerset, New Jersey: Eastern Analytical Symposium; Nov, 16-20, 1992.
6. Roy J, Bhuiyan K, Faruque A. Injectable ergometrine: Stability and packaging for developing countries. Indian Drugs1997;34:634-6. (Pubitemid 27523996)
7. Kumar V, Sunder N, Potdar A. Critical factors in developing pharmnaceutical formulations-An overview. Part 2. Pharm Technol 1992;16:86-8.
8. Smith A, Pennefather PM, Kaye SB. Fluoroquinolones-place in ocular therapy. Drugs 2001;61:747-61.
9. Roy J, Das SC. The effect of sunlight on ciprofloxacin eye drops. 2010. [In press].
10. Riley TN. Steric aspects of drug action. Pharmacist 1998;23:40-51.
11. Hatakka H, Alatalo H, Palosaari S. Effect of Impurities and additives on crystal Growth Available from: http://www2.lut.fi/~hhatakka/docit/impure.html. [Last accessed on 2010].
12. Jacobs P, Dewe W, Flament A. A new validation approach applied to the GC determination of impurities in organic solvents. J Pharm Biomed Anal 2005;40:294-304.
13. Gimeno P, Besacier F, Bottex M, Dujourdy L, Chaudron-Thozet H. A study of impurities in intermediates and 3, 4 methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes. Forensic Sci Int 2005;155:141-57. (Pubitemid 41454951)
14. Ahuja S. Impurities Evaluation of Pharmaceuticals. New York: Marcel Dekker; 1998. p. 142.
15. Humfrey C. Keeping afloat in a sea of impurities, Global Safety Assessment AstraZeneca. London: R and D, SCI; Jun 07, 2007.
16. Markovic I. Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: A risk-based perspective. Informa 2007;6:487-91. (Pubitemid 351308208)
17. Bari SB, Kadam BR, Jaiswal YS. Impurity profile: Significance in Active Pharmaceutical Ingredient. Eurasian J Anal Chem 2007;2:1.
18. Peter JS, Ahmed A, Yan W. An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compound. J Pharm Biomed Anal 2006;41:883-90.
19. Radhakrishna T, Satynarayana J, Satynarayana A. Determination of Loratidine and its Related Impurities by HPLC. Indian Drugs 2002;39:342.
20. Radhakrishna T, Satynarayana J, Satynarayana A. HPLC method for the Degradation of Celecoxib and its Related Impurities. Indian Drugs 2002;40:166.
21. Zawilla NH, Li B, Hoogmartens J. Improved RP-LC method combined with pulsed electrochemical detection for the analysis of amikacin. J Pharm Biomed Anal 2006;42:114.
22. Still WC, Kahn M, Mitra A. Flash chromatography. J Org Chem 1978;43:2923-5.
23. Donald LP, Gary ML. Introduction to Organic Laboratory Techniques. Vol. 4. Thomson Brooks; 2006. p. 797-817.
24. Look DC, Jones RL, Cantwell G. Characterization of homoepitaxial p-type ZnO grown by molecular beam epitaxy. Appl Phys Lett 2002;81:1830.
25. Buckau G, Duschner H, Psarros N. Characterization of humic and fulvic acids from Gorleben groundwater. Fresenius J Anal Chem 1990;338:245-52. (Pubitemid 20340169)
26. Gonon P, Gheeraert E, Deneuville A.Characterization of heavily B-doped polycrystalline diamond films using Raman spectroscopy and electron spin resonance. J Appl Phys 1995;78:7059-2.
27. Lohr LL, Sharp TR, Alsante KM. Isolation and Identification of Process Related Impurities and Degradation Products from Pharmaceutical Drug Candidates. Part 2: The Roles of NMR and Mass Spectrometry. Am Pharm Rev 2001;14:232-9. available from:http://www.americanpharmaceuticalreview.com/past-articles-f.htm [Last accessed on 2010].